Type 2 Diabetes Medications and Glaucoma Risk episode artwork

EPISODE · Jan 30, 2025 · 17 MIN

Type 2 Diabetes Medications and Glaucoma Risk

from Ophthalmology Journal

How do GLP-1 receptor agonists and metformin affect glaucoma risk in patients with Type 2 diabetes? Join Dr. Ike Ahmed and Jawad Muayad as they discuss the data on diabetes treatments and glaucoma risk with Dr. Emily Schehlein. From their Ophthalmology article, "Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes." Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes. Muayad, Jawad et al. Ophthalmology. In press.

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

Ready to play

Type 2 Diabetes Medications and Glaucoma Risk

0:00 17:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Ophthalmology Journal?

This episode is 17 minutes long.

When was this Ophthalmology Journal episode published?

This episode was published on January 30, 2025.

Can I download this Ophthalmology Journal episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!